Immatics (IMTX) Stock Price

Immatics Price

Frankfurt·CLOSED
8.20EUR-0.56 (-6.60 %)
Market closed

Over the last 7 years Immatics grew revenue by 43.9% annually, reaching 48.27 M EUR. For Immatics, the net margin of -407.0% is down versus -273.5% a few years ago. The consensus 12-month price target for Immatics is 15.51 EUR, about 89.1% above where the stock trades today. Of 17 analysts, 16 rate the stock a buy — an overall Buy consensus. The stock trades about 84% above its 52-week low.

Immatics stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Immatics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Immatics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Immatics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Immatics Stock Price History
DateImmatics Price
8/5/20268.20 EUR
7/31/20268.76 EUR
7/29/20268.99 EUR
7/6/20268.74 EUR
7/2/20268.70 EUR
7/1/20268.62 EUR
6/30/20268.86 EUR
6/29/20268.36 EUR
6/26/20268.33 EUR
6/25/20268.33 EUR
6/24/20268.76 EUR
6/23/20268.67 EUR
6/22/20268.55 EUR
6/18/20268.55 EUR
6/17/20268.33 EUR
6/16/20267.95 EUR
6/15/20268.25 EUR
6/12/20268.20 EUR
6/11/20267.92 EUR
6/10/20267.76 EUR
6/9/20268.01 EUR
6/8/20268.06 EUR
6/5/20268.56 EUR
6/4/20268.90 EUR
6/3/20268.93 EUR
6/2/20268.78 EUR
6/1/20269.74 EUR
5/29/202610.07 EUR
5/28/202610.01 EUR
5/27/20269.96 EUR
5/26/20269.79 EUR
5/22/202610.16 EUR
5/21/20269.67 EUR
5/20/20269.81 EUR
5/19/20269.36 EUR
5/18/20269.29 EUR
5/15/20269.51 EUR
5/14/20269.77 EUR
5/13/20269.44 EUR
5/12/20269.96 EUR
5/11/202610.09 EUR
5/8/20269.94 EUR
5/7/20269.74 EUR
5/6/202610.07 EUR
5/5/20269.58 EUR
5/4/20269.74 EUR
5/1/20269.44 EUR
4/30/20269.61 EUR
4/29/20269.80 EUR
4/28/202610.14 EUR
4/27/20269.93 EUR
4/24/20269.93 EUR
4/23/20269.75 EUR
4/22/20269.85 EUR
4/21/20269.78 EUR
4/20/20269.84 EUR
4/17/20269.77 EUR
4/16/20269.51 EUR
4/15/20269.62 EUR
4/14/20269.58 EUR
4/13/20269.51 EUR
4/10/20269.12 EUR
4/9/20269.32 EUR
4/8/20269.21 EUR
4/7/20268.97 EUR
4/6/20269.02 EUR
4/2/20269.05 EUR
4/1/20268.76 EUR
3/31/20268.61 EUR
3/30/20268.13 EUR
3/27/20268.20 EUR
3/26/20268.55 EUR
3/25/20268.52 EUR
3/24/20268.05 EUR
3/23/20268.32 EUR
3/20/20268.25 EUR
3/19/20268.49 EUR
3/18/20268.47 EUR
3/17/20268.60 EUR
3/16/20268.58 EUR
3/13/20268.08 EUR
3/12/20268.23 EUR
3/11/20268.77 EUR
3/10/20269.18 EUR
3/9/20268.75 EUR
3/6/20268.62 EUR
3/5/20268.88 EUR
3/4/20268.90 EUR
3/3/20268.61 EUR
3/2/20268.74 EUR
2/27/20269.04 EUR
2/26/20268.86 EUR
2/25/20269.00 EUR
2/24/20268.95 EUR
2/23/20268.66 EUR
2/20/20268.80 EUR
2/19/20269.01 EUR
2/18/20268.70 EUR
2/17/20268.69 EUR
2/13/20268.61 EUR
2/12/20268.66 EUR
2/11/20268.97 EUR
2/10/20268.69 EUR
2/9/20269.01 EUR
2/6/20268.42 EUR
2/5/20267.50 EUR
2/4/20268.17 EUR
2/3/20268.70 EUR
2/2/20268.74 EUR
1/30/20268.35 EUR
1/29/20268.20 EUR
1/28/20268.48 EUR
1/27/20268.74 EUR
1/26/20268.51 EUR
1/23/20268.67 EUR
1/22/20268.88 EUR
1/21/20268.73 EUR
1/20/20268.63 EUR
1/16/20268.60 EUR
1/15/20268.68 EUR
1/14/20268.60 EUR
1/13/20268.20 EUR
1/12/20268.01 EUR
1/9/20268.02 EUR
1/8/20268.15 EUR
1/7/20268.61 EUR
1/6/20268.40 EUR
1/5/20268.53 EUR
1/2/20269.14 EUR
12/31/20259.18 EUR
12/30/20258.81 EUR
12/29/20258.86 EUR
12/26/20258.94 EUR
12/24/20259.07 EUR
12/23/20258.94 EUR
12/22/20259.05 EUR
12/19/20258.98 EUR
12/18/20258.37 EUR
12/17/20258.68 EUR
12/16/20258.83 EUR
12/15/20258.73 EUR
12/12/20258.78 EUR
12/11/20258.78 EUR
12/10/20258.80 EUR
12/9/20258.82 EUR
12/8/20258.99 EUR
12/5/20258.90 EUR
12/4/202510.38 EUR
12/3/20259.04 EUR
12/2/20258.65 EUR
12/1/20258.97 EUR
11/28/20259.35 EUR
11/26/20259.28 EUR
11/25/20259.59 EUR
11/24/20259.27 EUR
11/21/20258.92 EUR
11/20/20258.83 EUR
11/19/20259.03 EUR
11/18/20259.03 EUR
11/17/20258.28 EUR
11/14/20258.92 EUR
11/13/20258.73 EUR
11/12/20259.33 EUR
11/11/20258.04 EUR
11/10/20257.90 EUR
11/7/20257.92 EUR
11/6/20258.07 EUR
11/5/20257.82 EUR
11/4/20258.09 EUR
11/3/20258.47 EUR
10/31/20258.91 EUR
10/30/20259.11 EUR
10/29/20259.04 EUR
10/28/20259.06 EUR
10/27/20259.25 EUR
10/24/20258.90 EUR
10/23/20258.90 EUR
10/22/20258.86 EUR
10/21/20259.21 EUR
10/20/20259.59 EUR
10/17/20258.63 EUR
10/16/20258.92 EUR
10/15/20259.47 EUR
10/14/20258.90 EUR
10/13/20258.83 EUR
10/10/20259.06 EUR
10/9/20259.53 EUR
10/8/20259.07 EUR
10/7/20258.23 EUR
10/6/20258.21 EUR
10/3/20258.22 EUR
10/2/20257.64 EUR
10/1/20257.87 EUR
9/30/20257.45 EUR
9/29/20256.92 EUR
9/26/20256.73 EUR
9/25/20256.17 EUR
9/24/20256.41 EUR
9/23/20256.23 EUR
9/22/20255.99 EUR
9/19/20255.86 EUR
9/18/20255.78 EUR
9/17/20255.27 EUR
9/16/20255.25 EUR
9/15/20254.99 EUR
9/12/20255.09 EUR
9/11/20255.18 EUR
9/10/20255.08 EUR
9/9/20255.06 EUR
9/8/20255.08 EUR
9/5/20255.48 EUR
9/4/20255.00 EUR
9/3/20254.77 EUR
9/2/20254.67 EUR
8/29/20254.45 EUR
8/28/20254.62 EUR
8/27/20254.72 EUR
8/26/20254.68 EUR
8/25/20254.57 EUR
8/22/20254.98 EUR
8/21/20254.92 EUR
8/20/20254.90 EUR
8/19/20254.89 EUR
8/18/20255.43 EUR
8/15/20255.54 EUR
8/14/20255.16 EUR
8/13/20255.34 EUR
8/12/20255.62 EUR
8/11/20255.55 EUR
8/8/20255.41 EUR
8/7/20255.53 EUR
8/6/20255.55 EUR
Access this data via the Eulerpool API
Get Free API Key

Immatics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
54.00 M EUR
-101.73 M EUR
-96.99 M EUR
Jan 1, 2024
155.84 M EUR
-38.62 M EUR
15.22 M EUR
Jan 1, 2025
48.27 M EUR
-182.02 M EUR
-196.45 M EUR
Jan 1, 2026 (e)
43.25 M EUR
-22.55 M EUR
-236.40 M EUR
Jan 1, 2027 (e)
46.23 M EUR
-24.11 M EUR
-232.78 M EUR
Jan 1, 2028 (e)
113.79 M EUR
-59.34 M EUR
-206.57 M EUR
Jan 1, 2029 (e)
242.44 M EUR
-126.43 M EUR
-140.41 M EUR
Jan 1, 2030 (e)
464.06 M EUR
-242.00 M EUR
-23.51 M EUR

Immatics Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 10:10 PM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
SHARESM
201820192020202120222023202420252026e2027e2028e2029e2030e2031e
3.0018.0031.0034.00172.0053.00155.0048.0043.0046.00113.00242.00464.00660.00
–500.0072.229.68405.88-69.19192.45-69.03-10.426.98145.65114.1691.7442.24
-1,000.00-116.67-112.90-152.9438.37-120.75100.00100.00100.00100.00100.00100.00100.00100.00
-30.00-21.00-35.00-52.0066.00-64.00155.0048.0043.0046.00113.00242.00464.00660.00
-34.00-33.00-69.00-86.0029.00-101.00-38.00-182.00-22.00-24.00-59.00-126.00-241.00–
-1,133.33-183.33-222.58-252.9416.86-190.57-24.52-379.17-51.16-52.17-52.21-52.07-51.94–
-31.00-31.00-229.00-95.0037.00-96.0015.00-196.00-236.00-232.00-206.00-140.00-23.0056.00
––638.71-58.52-138.95-359.46-115.63-1,406.6720.41-1.69-11.21-32.04-83.57-343.48
62.9162.9162.9163.4068.2184.66106.80126.05126.05126.05126.05126.05126.05126.05
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Immatics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Immatics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Immatics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Immatics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Immatics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Immatics stock margins

The Immatics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Immatics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Immatics.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
-151.92 %
-248.24 %
-273.45 %
Jan 1, 2022
38.22 %
17.33 %
21.71 %
Jan 1, 2023
-119.76 %
-188.39 %
-179.63 %
Jan 1, 2024
100.00 %
-24.78 %
9.77 %
Jan 1, 2025
100.00 %
-377.11 %
-407.01 %
Jan 1, 2026 (e)
100.00 %
-52.15 %
-546.62 %
Jan 1, 2027 (e)
100.00 %
-52.15 %
-503.52 %
Jan 1, 2028 (e)
100.00 %
-52.15 %
-181.53 %

Immatics Stock Revenue, EBIT, Earnings per Share

The Immatics earnings per share therefore indicates how much revenue Immatics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.55 EUR
-1.36 EUR
-1.50 EUR
Jan 1, 2022
2.53 EUR
0.44 EUR
0.55 EUR
Jan 1, 2023
0.64 EUR
-1.20 EUR
-1.15 EUR
Jan 1, 2024
1.46 EUR
-0.36 EUR
0.14 EUR
Jan 1, 2025
0.38 EUR
-1.44 EUR
-1.56 EUR
Jan 1, 2026 (e)
0.36 EUR
-0.18 EUR
-1.94 EUR
Jan 1, 2027 (e)
0.38 EUR
-0.19 EUR
-1.91 EUR
Jan 1, 2028 (e)
0.94 EUR
-0.47 EUR
-1.70 EUR

Immatics business model & stock analysis

Immatics Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Immatics Employees
Details
Date
Immatics Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Immatics Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Immatics historical P/E ratio, EBIT multiple, and P/S ratio

Immatics annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Immatics shares outstanding

The number of shares of Immatics was 126.05 M in 2025. This indicates how many shares Immatics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
63.40 M Stocks
Jan 1, 2022
68.21 M Stocks
Jan 1, 2023
84.66 M Stocks
Jan 1, 2024
106.80 M Stocks
Jan 1, 2025
126.05 M Stocks
Jan 1, 2026 (e)
126.05 M Stocks
Jan 1, 2027 (e)
126.05 M Stocks
Jan 1, 2028 (e)
126.05 M Stocks

Current Immatics forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
94.12 % (16)
Hold
5.88 % (1)
Sell
0.00 % (0)
12M Price Target
15.51
Last Price
8.76
Currency
EUR
12M Return Potential
77.02 %
LTM Return
0 %

Immatics Analyst Rating Actions

DateFirmActionRatingReliability
5/19/2026
Chardan Capital
Chardan Capital
MaintainedBuy–
11/24/2025
Chardan Capital
Chardan Capital
MaintainedBuy–
11/19/2025
Mizuho
Mizuho
MaintainedOutperform31
11/18/2025
Guggenheim
Guggenheim
MaintainedBuy30
4/1/2025
Cantor Fitzgerald
Cantor Fitzgerald
MaintainedOverweight44
11/19/2024
B of A Securities
B of A Securities
MaintainedBuy70
5/16/2024
Mizuho
Mizuho
MaintainedBuy31
3/31/2023
Mizuho
Mizuho
MaintainedBuy31
3/23/2023
Chardan Capital
Chardan Capital
MaintainedBuy–
8/10/2022
Chardan Capital
Chardan Capital
MaintainedBuy–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Immatics Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/11/2026-0.44EUR-10.71 MEUR-2026 Q2
5/11/2026-0.40EUR-11.07 MEUR-2026 Q1
3/25/2026-0.38EUR-9.87 MEUR-2025 Q4
11/17/2025-0.40EUR-10.87 MEUR-2025 Q3
8/11/2025-0.33EUR-14.08 MEUR-2025 Q2
11/12/2024-0.26EUR-16.44 MEUR-2024 Q3
5/14/2024-0.27EUR-16.82 MEUR-2024 Q1
3/19/2024-0.33EUR-14.26 MEUR-2023 Q4
11/29/2022-0.44EUR-12.27 MEUR-2022 Q3

Immatics shareholder structure

% Name
17.81191%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
10.58682%
RTW INVESTMENTS, LP
RTW INVESTMENTS, LP
9.20544%
SUVRETTA CAPITAL MANAGEMENT, LLC
SUVRETTA CAPITAL MANAGEMENT, LLC
8.98050%
BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP
8.54184%
PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC
6.11743%
TORONTO DOMINION BANK
TORONTO DOMINION BANK
...

Immatics Beneficial Ownership Filings (SEC 13D/G)

Free Float
83.7%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
27.30%
Prof. Dr. Friedrich von Bohlen und Halbach
Prof. Dr. Friedrich von Bohlen und Halbach
SEC ↗
27.30%
Prof. Dr. Christof Hettich
Prof. Dr. Christof Hettich
SEC ↗
27.30%
Oliver Hopp
Oliver Hopp
SEC ↗
27.30%
OH Beteiligungen GmbH & Co. KG
OH Beteiligungen GmbH & Co. KG
SEC ↗
27.30%
Dr. Mathias Hothum
Dr. Mathias Hothum
SEC ↗
27.30%
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG
SEC ↗
27.30%
Dietmar Hopp
Dietmar Hopp
SEC ↗
27.30%
DH-Capital GmbH & Co. KG
DH-Capital GmbH & Co. KG
SEC ↗
27.30%
Daniel Hopp
Daniel Hopp
SEC ↗
26.20%
Mathias Hothum
Mathias Hothum
SEC ↗

Immatics Executives and Management Board

17 members · avg. age 57 · 12 % women

HS

Dr. Harpreet Singh (50)

Chief Executive Officer, Executive Director · since 2020

3.51 M EUR

Management

AC

Mr. Arnd Christ (58)

Chief Financial Officer

–
SW

Dr. Steffen Walter (48)

Chief Operating Officer · since 2023

–
ES

Mr. Edward Sturchio (49)

General Counsel

–
CB

Dr. Cedrik Britten (50)

Chief Medical Officer

–
RK

Dr. Rainer Kramer (61)

Chief Business Officer

–
CR

Dr. Carsten Reinhardt (58)

Chief Development Officer

–

Board of Directors

PC

Mr. Peter Chambre (69)

Non-Executive Chairman of the Board · since 2020

370,000.00 EUR
MA

Mr. Michael Atieh (71)

Non-Executive Independent Director

353,000.00 EUR
PC

Mr. Paul Carter (64)

Non-Executive Independent Director

348,000.00 EUR
EF

Dr. Eliot Forster (58)

Non-Executive Independent Director

335,000.00 EUR
HM

Ms. Heather Mason (64)

Non-Executive Independent Director

333,000.00 EUR
AS

Mr. Adam Stone (45)

Non-Executive Independent Director

333,000.00 EUR

Immatics Supply Chain

Immatics Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
5 companies
#NameTrend
1
CryoPort
Supplier·Health Care Equipment & Supplies·US
0.46
0.88
0.36
0.84
0.86
0.46
2
Genmab
Supplier·Customer·Biotechnology·DK
-0.06
0.59
0.29
0.51
0.72
0.33
#NameTrend
1
Bristol-Myers Squibb
Supplier·Customer·Pharmaceuticals·US
0.35
0.67
0.19
-0.74
-0.65
-0.47
2
GlaxoSmithKline
Supplier·Customer·Pharmaceuticals·GB
-0.69
-0.43
0.41
-0.18
-0.61
-0.23
3
Amgen
Supplier·Customer·Biotechnology·US
0.62
0.60
0.24
-0.54
-0.43
-0.22

Frequently asked questions about Immatics

Analysts currently set an average price target of 16.66 EUR for the Immatics stock (median: 15.51 EUR), implying +90.2 % versus the latest price. The consensus is based on 17 analyst ratings.

Immatics Analyst Price Targets 2026

17 analysts currently rate the Immatics stock: 16 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Immatics to generate revenue of 43.25 M EUR and earnings per share of -1.88 EUR.

Immatics Analyst Price Targets 2026

The Immatics share (IMTX) is listed on 4 stock exchanges, including: NASDAQ (IMTX), Frankfurt (4A3.F), München (4A3.MU), Düsseldorf (4A3.DU).

No history available for Immatics.

The expected revenue of Immatics is 43.25 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Immatics is -236.40 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Immatics is currently -4.37. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Immatics stock.

The price-to-sales ratio (P/S) of Immatics is currently 23.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Immatics stock.

The Eulerpool Quality Score for Immatics is 1/10.

The ISIN of Immatics is NL0015285941. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Immatics is A2P72S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Immatics is IMTX. The ticker symbol is used to trade Immatics shares on the stock exchange.

Immatics paid dividends every year for the past 0 years.

Immatics is assigned to the 'Health' sector.

The dividends of Immatics are distributed in EUR.

All fundamentals and in-depth analysis of Immatics

Our stock analysis for Immatics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immatics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Immatics Stock
Immatics Revenue→
Immatics Stock
Immatics Net Income→
Immatics Stock
Immatics P/E→
Immatics Stock
Immatics P/S→
Immatics Stock
Immatics EBIT→
Immatics Stock
Immatics Dividend→
Immatics Stock
Immatics Directors Dealings→
Immatics Stock
Immatics Stocks→
Immatics Stock
Immatics Market capitalization→
Immatics Stock
Immatics Debt→
Immatics Stock
Immatics Liabilities→
Immatics Stock
Immatics Equity→
Immatics Stock
Immatics AAQS→
Immatics Stock
Immatics Employees→
Immatics Stock
Immatics ROE→
Immatics Stock
Immatics ROA→
Immatics Stock
Immatics ROCE→
Immatics Stock
Immatics News→
Immatics Stock
Immatics Analyst Price Targets→

Health Stocks

Immix BiopharmaImexpharmImmuCellImExHSImmuneeringImeik Technology Development CoImmuneOncia TherapeuticsIMD International Medical Devices SpAImmuneOnco Biopharmaceuticals ShanghaiImaraImmunicImagion BiosystemsAll Stocks A–Z →